ゲノム編集/ゲノム工学の世界市場予測（～2022年）：技術（CRISPR、TALEN、ZFN）、用途、エンドユーザー...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Research
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Data Validation and Triangulation
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 28)

4 Premium Insights (Page No. – 32)
4.1 Genome Editing: Market Overview
4.2 Europe: Genome Editing Market, By Application
4.3 Genome Editing Market, By End User
4.4 Genome Editing Market, By Country/Region

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
5.2.1.2 Growing Application Areas of Genomics
5.2.1.3 High Prevalence of Infectious Diseases and Cancer
5.2.1.4 Technological Advancements
5.2.1.5 Increasing Production of Genetically Modified Crops
5.2.2 Restraints
5.2.2.1 Dearth of Trained Professionals
5.2.2.2 Adverse Public Perception of Genetic Research
5.2.3 Opportunities
5.2.3.1 Use of Genome Editing in Specialized/Personalized Medicine
5.2.3.2 Emerging Markets
5.2.4 Challenges
5.2.4.1 High Cost of Genomics Equipment
5.2.4.2 Off-Target Effect of Crispr
5.2.4.3 Secure Storage of Large Volumes of Sequenced Data

6 Genome Editing Market, By Technology (Page No. – 43)
6.1 Introduction
6.2 Crispr
6.3 Talen
6.4 ZFN
6.5 Antisense
6.6 Other Technologies

7 Genome Editing Market, By Application (Page No. – 51)
7.1 Introduction
7.2 Cell Line Engineering
7.3 Genetic Engineering
7.3.1 Animal Genetic Engineering
7.3.2 Plant Genetic Engineering
7.4 Other Applications

8 Genome Editing Market, By End User (Page No. – 60)
8.1 Introduction
8.2 Biotechnology & Pharmaceutical Companies
8.3 Academic & Government Research Institutes
8.4 Contract Research Organizations

9 Genome Editing Market, By Region (Page No. – 65)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Research Grants and Funding By Government Institutes
9.2.1.2 Increasing Use of Gm Crops
9.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias in the US
9.2.1.4 Genome Editing Conferences in the US
9.2.1.5 Increasing Prevalence of Cancer
9.2.1.6 Strategic Developments in the US Market
9.2.2 Canada
9.2.2.1 Availability of Research Funding in Canada
9.2.2.2 Rising Incidence of Cancer
9.2.2.3 Gapp to Intensify Genomic R&D
9.3 Europe
9.3.1 Germany
9.3.1.1 Presence of A Large Number of Academic Institutes
9.3.1.2 Availability of Funding for Life Science Research
9.3.1.3 Conferences/Meetings/Symposiums/Workshops in Germany
9.3.2 UK
9.3.2.1 Increasing Funds and Grants By Government Bodies
9.3.2.2 100,000 Genomes Project in the UK
9.3.3 France
9.3.3.1 Increasing Government Investments in Genomics
9.3.3.2 Introduction of Noninvasive Prenatal Testing in France
9.3.4 RoE
9.3.4.1 Spain’s Focus on Research
9.3.4.2 Growth in the Italian Biotech and Pharma Sectors
9.3.4.3 Growing Research Investments in Sweden & Denmark
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Government Initiatives to Support Healthcare Research in China
9.4.1.2 Efforts of BGI to Boost the Genomics Market in China
9.4.1.3 High Intensity of R&D Activities in China
9.4.2 Japan
9.4.2.1 Increasing Government Focus on Cancer Research
9.4.2.2 Conferences and Symposiums on Genetic Engineering in Japan
9.4.2.3 Focus on Cancer Research and Treatment
9.4.3 India
9.4.3.1 Emergence of Local Players in India Backed By Government Funding
9.4.3.2 Increasing Support for Biotech Start-UPS
9.4.3.3 Growth of the Pharmaceutical Industry in India
9.4.4 RoAPAC
9.4.4.1 Alliances and Partnerships in the Australian Market
9.4.4.2 Genome Asia 100k Initiative
9.4.4.3 Crop Research Initiatives in Asia
9.5 RoW
9.5.1 Latin America
9.5.1.1 Alliances, Availability of Government Funding in Brazil
9.5.1.2 Conferences & Workshops in Brazil (2016-2017)
9.5.2 Middle East and Africa
9.5.2.1 Genetic Testing and Genomic Analysis in the Middle East
9.5.2.2 Rising Prevalence of HIV and Cancer in Africa

10 Competitive Landscape (Page No. – 117)
10.1 Key Developments By Leading Players in the Genome Editing Market (2014-2017)
10.2 Market Share Analysis
10.2.1 Thermo Fisher Scientific
10.2.2 Merck
10.2.3 Horizon Discovery Group
10.3 Competitive Scenario
10.3.1 Agreements, Collaborations, and Partnerships
10.3.2 Product & Service Launches, By Company
10.3.3 Acquisitions
10.3.4 Expansions

11 Company Profiles (Page No. – 125)
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
11.1 Thermo Fisher Scientific
11.2 Merck
11.3 Horizon Discovery Group
11.4 Genscript
11.5 Sangamo Biosciences
11.6 Integrated Dna Technologies
11.7 Lonza
11.8 New England Biolabs
11.9 Origene Technologies
11.10 Transposagen Biopharmaceuticals
11.11 Editas Medicine
11.12 Crispr Therapeutics

*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 156)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details